Health Library

Our Health Library information does not replace the advice of a doctor. The health library is made available to assist our patients to learn more about their health.

alemtuzumab

Pronunciation: AL em TOOZ ue mab

Brand: Campath, Lemtrada

What is the most important information I should know about alemtuzumab?

Alemtuzumab can cause life-threatening side effects.

Call your doctor if you have unusual bruising or bleeding, blood in your urine or vomit, swelling in your feet, fever, swollen glands, muscle aches, diarrhea, or if you feel very weak or tired.

Some side effects may occur during the injection or shortly afterward. You will be watched closely for at least 2 hours after receiving alemtuzumab.

Alemtuzumab can have long lasting effects on your body. You may need medical tests for up to 4 years after you stop using this medicine.

What is alemtuzumab?

Alemtuzumab is an antibody made from animal DNA.

Alemtuzumab is used to treat chronic B-cell lymphocytic leukemia or relapsing forms of multiple sclerosis.

Lemtrada is available only from a certified pharmacy under a special program.

Alemtuzumab may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving alemtuzumab?

You should not receive alemtuzumab if you are allergic to it. You should not be treated with Lemtrada if you have HIV (human immunodeficiency virus).

Tell your doctor if you have ever had:

  • an active or recent infection;
  • kidney disease;
  • a thyroid disorder;
  • a bleeding or blood clotting disorder such as hemophilia; or
  • if you have received a vaccine in the past 6 weeks.

Alemtuzumab may cause other types of cancer, such as melanoma, thyroid cancer, or blood cancers. Ask your doctor about this risk.

Alemtuzumab may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 4 months after your last dose. Tell your doctor if you become pregnant.

You should not breast-feed while using alemtuzumab.

How is alemtuzumab given?

Alemtuzumab is given as an infusion into a vein. How often you receive alemtuzumab will depend on why you are using this medicine. Follow your doctor's instructions.

You may be given other medicines to help prevent certain side effects. Take these medicines for the full prescribed length of time.

You will be watched closely for at least 2 hours after receiving alemtuzumab, to make sure you do not have a serious reaction.

Alemtuzumab affects your immune system. You may get infections more easily, even serious or fatal infections. Your doctor will need to examine you on a regular basis.

Alemtuzumab can have long lasting effects on your body. You may need medical tests for up to 4 years after you stop using this medicine.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your alemtuzumab injection.

What happens if I overdose?

Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while receiving alemtuzumab?

Avoid foods that may be a source of Listeria infection, or heat them thoroughly before consuming. This includes deli meat, undercooked meat, seafood, poultry, unpasteurized dairy products, or soft cheeses.

Avoid being near people who are sick or have infections. Avoid activities that may increase your risk of bleeding or injury.

Do not receive a "live" vaccine while using alemtuzumab, or you could develop a serious infection. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), and zoster (shingles).

What are the possible side effects of alemtuzumab?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection or shortly afterward. Tell your caregiver if you feel weak, dizzy, itchy, nauseated, chilled or feverish, or if you have chest tightness or trouble breathing.

Alemtuzumab can cause your immune system to attack cells and organs in your body. This can lead to life-threatening medical problems such as severe bleeding or kidney damage. Call your doctor right away if you have:

  • unusual bruising or bleeding;
  • blood in your urine;
  • swelling in your legs or feet; or
  • if you cough up blood.

Also call your doctor at once if you have:

  • pain or swelling in your neck or throat, trouble swallowing;
  • a mole that has changed in size or color;
  • gallbladder symptoms --stomach pain, fever, nausea, vomiting;
  • lung problems --cough, wheezing, chest pain, feeling short of breath;
  • signs of infection --fever, swollen glands, muscle aches, weakness, pale or yellowed skin, diarrhea, dark colored urine, pain or burning when you urinate;
  • symptoms of herpes virus --cold sores around your mouth, skin sores or blisters, itching, tingling, burning pain in your thigh or lower back; or
  • thyroid problems --extreme tired feeling, nervousness, fast heartbeats, heavy sweating, constipation, weight gain or loss, swelling of your eyes, feeling cold.

Common side effects may include:

  • nausea, vomiting, stomach pain, diarrhea;
  • infections;
  • headache, joint pain, back pain;
  • itching, rash, tingling;
  • dizziness, tiredness, sleep problems (insomnia);
  • vaginal itching or discharge;
  • stuffy nose, throat pain or itching, white patches in your mouth or throat; or
  • flushing (warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect alemtuzumab?

Tell your doctor about all your other medicines. Some may affect alemtuzumab, especially:

  • drugs that weaken the immune system such as cancer medicine, or medicines to prevent organ transplant rejection.

This list is not complete. Other drugs may affect alemtuzumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Where can I get more information?

Your doctor or pharmacist can provide more information about alemtuzumab.


Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2018 Cerner Multum, Inc. Version: 4.01. Revision date: 3/14/2018.

Your use of the content provided in this service indicates that you have read, understood and agree to the End-User License Agreement, which can be accessed by End-User License Agreement, which can be accessed by clicking on this link.